Cargando…
Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review
INTRODUCTION: Primary hyperparathyroidism is increasingly an asymptomatic disease at diagnosis, but the recognized guidelines for management are based on evidence obtained from studies on patients with symptomatic disease, and surgery is not always indicated. Other patients are unable to undergo sur...
Autores principales: | Leere, Julius Simoni, Karmisholt, Jesper, Robaczyk, Maciej, Vestergaard, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397399/ https://www.ncbi.nlm.nih.gov/pubmed/28473803 http://dx.doi.org/10.3389/fendo.2017.00079 |
Ejemplares similares
-
Corrigendum: Contemporary Medical Management of Primary Hyperparathyroidism: A Systematic Review
por: Leere, Julius Simoni, et al.
Publicado: (2017) -
Associations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: A retrospective cohort study
por: Leere, Julius Simoni, et al.
Publicado: (2018) -
Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level
por: Chertok Shacham, Elena, et al.
Publicado: (2023) -
Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study
por: Emmanuel, Thomas, et al.
Publicado: (2020) -
The Russian registry of primary hyperparathyroidism, latest update
por: Mokrysheva, Natalia G., et al.
Publicado: (2023)